Publication | Closed Access

Isoliquiritigenin protects against sepsis-induced lung and liver injury by reducing inflammatory responses

Acute Lung InjuryInflammationInflammatory ResponsesInflammatory Lung DiseaseSepsis-induced LungLiver InjuryLiver PhysiologyInnate Immune SystemImmunologyChronic InflammationSepsisImmune MediatorMedicineInflammatory DiseaseDrug-induced Liver InjuryOxidative Stress